Efficacy and safety of infliximab-biosimilar compared to other biological drugs in rheumatoid arthritis: a mixed treatment comparison

OBJECTIVE: The aim of this meta-analysis was to compare the efficacy and safety of infliximab-biosimilar and other available biologicals for the treatment of rheumatoid arthritis (RA), namely abatacept, adalimumab, certolizumab pegol, etanercept, golimumab, infliximab, rituximab and tocilizumab. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Baji, Petra, Péntek, Márta, Czirják, László, Szekanecz, Zoltán, Nagy, György, Gulácsi, László, Brodszky, Valentin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046078/
https://www.ncbi.nlm.nih.gov/pubmed/24832836
http://dx.doi.org/10.1007/s10198-014-0594-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046078/
https://www.ncbi.nlm.nih.gov/pubmed/24832836
http://dx.doi.org/10.1007/s10198-014-0594-4

Ejemplares similares